1.
JAMA
; 330(13): 1223-1224, 2023 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37713185
RESUMO
This Viewpoint discusses how limited-supply agreements (introduction of generic products in reduced volumes) might thwart efforts to negotiate lower prices on prescription drugs in the US.